Increasing evidence suggests that COVID-19 is primarily an endothelial disease (32), characterized by elevated levels of PAI-1 and vWF, heightened platelet activation, and a hypercoagulable state, resulting in venous, arterial, and microvascular thrombosis. Here, VWF is linked to COVID-19.